Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’ by Steve Jones March 27, 2024March 27, 2024 Regulators must police the import of overseas products far more tightly as local producers flagged GMP […]
Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’ by Steve Jones March 11, 2024March 11, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024July 16, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
ECS Botanics chases in-house product growth after A$4m capital raise by Steve Jones February 22, 2024February 22, 2024
ECS strikes another offtake agreement, bringing total to $60m in 18 months by Martin Lane February 1, 2024November 25, 2024
ECS Botanics boosts product range along with MD’s salary by Martin Lane November 13, 2023November 13, 2023
ECS Botanics and MediCann Health strike A$24m offtake deal by Martin Lane October 3, 2023April 30, 2024
ECS Botanics reports record revenue and positive EBITDA for FY23 by Martin Lane August 31, 2023April 30, 2024
